https://scitechdaily.com/new-covid-variant-eris-on-the-rise/
SARS-CoV-2 lineage EG.5.1 has an advantage at evading neutralizing antibodies. When vaccinated or infected, our immune system creates antibodies that target the spike protein of SARS-CoV-2, blocking the virus from entering and multiplying inside cells. In tur…
Create an account or login to join the discussion